[Image courtesy of Phillips-Medisize]
Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector.Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.
Get the full story at our sister site, Drug Delivery Business News.
Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.
The company plans to display the pen at Pharmapack Europe, according to a news release.
“A pen injector is an important addition to Phillips-Medisize’s expanding product and platform portfolio that empowers biopharma companies to accelerate the rollout of novel and generic drug treatments at significant economies of scale,” said Paul Chaffin, SVP and president of medical and pharmaceutical solutions, Molex. “This ‘ready to go’ solution offers all of the advantages expected from ‘state of the art’ pen designs while be…
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops.
Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies.
More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some updates on some of those technologies, plus introductions to others, here are some more impressive developments you should keep an eye on:
1. Needle-free deliveryVaccines have become a major talking point over the past couple of years amid the COVID-19 pandemic and a number of companies are working on ways to deliver them, as well as other forms of medication, through different avenues.
A major speed bump in vaccine hesitancy can be fear of needles, so the introduction of needle-free drug delivery could make big waves in the space.
Two companies pushing forward with …
Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, the United Kingdom and the European Union.
Phillips-Medisize (Hudson, Wisconsin) is readying its global production facilities to keep pace with the anticipated demand for the Sotech Health breath analyzer. A Molex company, Phillips-Medisize has 36 facilities worldwide.
Get the full story on our sister site Medical Design & Outsourcing.
Sotech Health and Phillips-Medisize claim the breath analyzer can detect traces of the virus that causes COVID-19 within 30 seconds. [Image courtesy of Phillips-Medisize and Sotech Health]
Medtech contract manufacturing giant Phillips-Medisize used its human-factors product design expertise to help startup Sotech Health create what the companies claim is a breath sensor system that can detect COVID-19 in less than 30 seconds.Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, the United Kingdom and the European Union.
Phillips-Medisize (Hudson, Wisconsin) is readying its global production facilities to keep pace with the anticipated demand for the Sotech Health breath analyzer. A Molex company, Phillips-Medisize has 36 facilities worldwide.
The contract manufacturer boasts that its electronics, produ…
Phillips-Medisize and Exact Sciences (NSDQ:EXAS) today announced a collaboration to advance early cancer detection.
The collaboration centers around Exact Sciences’ Cologuard, the first and only FDA-approved, non-invasive stool DNA screening test for colorectal cancer, according to a news release.
Phillips-Medisize, a Molex company, said the collaboration will seek to focus on the patient experience through the simplicity and convenience of at-home testing. The company developed new tooling to safeguard against inadvertent leaks while meeting specifications and tolerances required to produce the highest levels of product quality.
Exact Sciences was able to utilize supply chain flexibility to acquire all components needed to rapidly scale production of the kit, while Phillips-Medisize located and validated alternate supply sources, conducted risk assessments and forecasting and created sourcing and procurement plans to protect against unplanned disr…
Phillips-Medisize announced today that it expanded its global manufacturing capacity through a number of collaborations and internal initiatives.
Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world.
Get the full story at our sister site, Medical Design & Outsourcing.
Phillips-Medisize announced today that it expanded its global manufacturing capacity through a number of collaborations and internal initiatives.
Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world.
“As the preferred partner for leading global customers, we continually invest in new talent and technologies that increase the capacity and capabilities of Phillips-Medisize across the entire value chain,” Molex president of medical & pharmaceutical solutions Paul Chaffin said in a news release. “Our expanded global reach and resources will enable us to solve complex development and manufacturing challenges while meeting escalating customer demands for more localized production, supply chain management and accelerated go-to-market strategies.”
P…
Phillips-Medisize Aria Smart Autoinjector platform featuring a reusable electronic drive unit and single-use, disposable cassettes [Image from Phillips-Medisize]
Phillips-Medisize today unveiled the Aria smart autoinjector platform designed to elevate patient care and reduce environmental impact.Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.
Get the full story at our sister site, Drug Delivery Business News.
Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.
Get the full story at our sister site, Drug Delivery Business News.
A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.
Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.
A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.
Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.